Search - tctmd.com

Displaying 121 - 138 of 138

Sort: Relevancy | Date

Presentation TCT 2014

The Informed Consent Process: More Complicated Than Informed!

Presenter: Roxana Mehran, Bernhard Witzenbichler, Somjot S. Brar, Theresa Franklin-Bond

September 13, 2014

Presentation TCT 2014

How to Be a Key Enroller in Clinical Trials: Building the Team!

Presenter: Roxana Mehran, Bernhard Witzenbichler, Somjot S. Brar, James C. Blankenship

September 13, 2014

Presentation TCT 2014

Guiding Principles in Clinical Research: The Essentials (GCP, IRB, Informed Consent, and Quality Assurance)

Presenter: Roxana Mehran, Bernhard Witzenbichler, Somjot S. Brar, Kate Dalton

September 13, 2014

Presentation TCT 2014

Setting-up a Thriving Clinical Research Program: The Basics and More

Presenter: Roxana Mehran, Bernhard Witzenbichler, Somjot S. Brar, David A. Cox

September 13, 2014

Presentation CIT 2014

CREDIT I: A First-In-Man Study of the Second Generation EXCEL Biodegradable PolymerSirolimus-Eluting Stent - 4-Month Clinical, Angiographic, and OCT Results

Presenter: Han Yaling

March 22, 2014

Presentation CTO 2014

EXCEL and NOBLE: Where do Left Main Trials Stand in the Shadows of SYNTAX and FREEDOM?

Presenter: Gregg W. Stone

March 01, 2014

Presentation Cell Therapy 2014

Biological and pre-clinical characterization of CD34+ cells before and after automated GMP Expansion as a pre-requisite for launching the EXCELLENT clinical trial

Presenter: Philippe Henon

January 22, 2014

Presentation

Mitraclip Tips and Tricks for Excellence

Presenter: Francesco Maisano

December 01, 2013

Presentation TCT 2013

Are Regulatory Approval Clinical Trials Too Complex and Too Costly for New Devices and New Indications? EXCEL and BVS Experience.

Presenter: Charles Simonton

October 30, 2013

Presentation TCT 2013

The Final Word in Left Main Stenting? Novel Aspects and Status Update of the EXCEL Trial

Presenter: Gregg Stone

October 28, 2013

Presentation SOLACI 2013

The EXCEL Trial: Novel Aspects and Status Update

Presenter: Gregg W. Stone

July 24, 2013

Presentation Cell Therapy 2013

EXCELLENT Trial Design

Presenter: J?r?me Roncalli

January 22, 2013

Presentation TCT 2012

What Will We Learn from the EXCEL Trial that We Do Not Already Know?

Presenter: Gregg Stone

October 23, 2012

Presentation TCT 2012

The EXCEL Trial: Novel Aspects and Status Update

Presenter: Gregg Stone

October 22, 2012

Presentation TCT 2012

Debate: Should ASD Closure Only be Done in SHD/CHD Centers of Excellence? NO

Presenter: John Carroll

October 22, 2012

Presentation TCT 2012

Debate: Should ASD Closure Only be Done in SHD/CHD Centers of Excellence? YES

Presenter: Ted Feldman

October 22, 2012

Presentation TCTAP 2012

The EXCEL Trial Design, Status, and Timelines

Presenter: Gregg W. Stone

April 26, 2012

Presentation TCT 2012

Applying the National Institute for Clinical Excellence criteria to patients treated with the Genous EPC capturing stent: A sub-study of the e-HEALING worldwide registry.

Presenter: Margo Klomp, Peter M. Damman, Marcel A. Beijk, Sigmund M. Silber, Manfred M. Grisold, Expedito E. Ribeiro, Harry Suryapranata, Jaroslaw J. W?jcik, Kui H. Sim, Jan G. Silber, Robbert J. de Winter

January 03, 2012

Advertisement

The Informed Consent Process: More Complicated Than Informed!

How to Be a Key Enroller in Clinical Trials: Building the Team!

Guiding Principles in Clinical Research: The Essentials (GCP, IRB, Informed Consent, and Quality Assurance)

Setting-up a Thriving Clinical Research Program: The Basics and More

CREDIT I: A First-In-Man Study of the Second Generation EXCEL Biodegradable PolymerSirolimus-Eluting Stent - 4-Month Clinical, Angiographic, and OCT Results

EXCEL and NOBLE: Where do Left Main Trials Stand in the Shadows of SYNTAX and FREEDOM?

Biological and pre-clinical characterization of CD34+ cells before and after automated GMP Expansion as a pre-requisite for launching the EXCELLENT clinical trial

Mitraclip Tips and Tricks for Excellence

Are Regulatory Approval Clinical Trials Too Complex and Too Costly for New Devices and New Indications? EXCEL and BVS Experience.

The Final Word in Left Main Stenting? Novel Aspects and Status Update of the EXCEL Trial

The EXCEL Trial: Novel Aspects and Status Update

EXCELLENT Trial Design

What Will We Learn from the EXCEL Trial that We Do Not Already Know?

The EXCEL Trial: Novel Aspects and Status Update

Debate: Should ASD Closure Only be Done in SHD/CHD Centers of Excellence? NO

Debate: Should ASD Closure Only be Done in SHD/CHD Centers of Excellence? YES

The EXCEL Trial Design, Status, and Timelines

Applying the National Institute for Clinical Excellence criteria to patients treated with the Genous EPC capturing stent: A sub-study of the e-HEALING worldwide registry.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content